Year archive

X BIOSCIENCE PUBLIC COMPANY LIMITED — 2024 filings

All 119 regulatory filings released by X BIOSCIENCE PUBLIC COMPANY LIMITED (XBIO) in 2024, sourced directly from the official regulator.

119 Filings

2024 Period

2024 filings (119)

Filing	Released	Lang
Report on the results of sale of common shares offered to private placement (F53-5) Share Issue/Capital Change	2024-12-27	English
Right Adjustment of W-W7 (Add Template) Share Issue/Capital Change	2024-12-27	English
Right Adjustment of W-W6 Share Issue/Capital Change	2024-12-25	English
Allotment of Additional Shares Under a General Mandate Share Issue/Capital Change	2024-12-25	English
Report on the results of the sale of warrants offered to All common shares' shareholders (F53-5) Share Issue/Capital Change	2024-12-25	English
Shareholders meeting's resolution Declaration of Voting Results & Voting Rights Announcements	2024-12-24	English
Disclosure of the Invitation Letter of the Extraordinary General Meeting of Shareholders No.1/2024 on the Company's Website Report Publication Announcement	2024-12-12	English
Announcement of Public Holidays 2025 Regulatory Filings	2024-12-02	English
Invitation to Shareholders to Propose Agenda Items and Nominate Candidates for Directorship for the AGM 2025 Regulatory Filings	2024-12-02	English
No Right Adjustment of W-W6 Regulatory Filings	2024-11-28	English
Report of the Public Presentation Regulatory Filings	2024-11-27	English
Notification convening date of the Public Presentation Report Publication Announcement	2024-11-22	English
Resolution Notification: Determination of the Record Date for Identifying Shareholders Eligible to Receive Warrant (W-W7) and the Issuance Date of Warrant (W-W7) to Shareholders (Revised : Add Templat Regulatory Filings	2024-11-19	English
The resolution re: determination of the Record Date for W-W7, capital increase under a General Mandate and RO, company name change, reduction of registered capital by decreasing the par value of share Capital/Financing Update	2024-11-18	English
New shares of W to be traded on November 18, 2024 Share Issue/Capital Change	2024-11-15	English
Progress Report on the Acquisition of Ordinary Shares of Fruita Biomed Company Limited as approved by Shareholders M&A Activity	2024-11-13	English
Financial Performance Quarter 3 (F45) (Reviewed) (Revised) Regulatory Filings	2024-11-12	English
Financial Statement Quarter 3/2024 (Reviewed) (Revised) Regulatory Filings	2024-11-12	English
Management Discussion and Analysis Quarter 3 Ending 30 Sep 2024 Management Reports	2024-11-12	English
Financial Performance Quarter 3 (F45) (Reviewed) Earnings Release Q3 2024	2024-11-12	English
Financial Statement Quarter 3/2024 (Reviewed) Regulatory Filings	2024-11-12	English
Notification of the Resolutions of the Company's Board of Directors Meeting No. 6/2024 regarding the Resignation of a Director, Appointment of a Replacement Director, and Amendment of Director Authori Board/Management Information	2024-11-12	English
New shares of W to be traded on November 11, 2024 Share Issue/Capital Change	2024-11-08	English
Report on the results of the Exercise of W-W5 (F53-5) Share Issue/Capital Change	2024-11-06	English
Report on the results of sale of common shares offered to private placement (F53-5) Share Issue/Capital Change	2024-11-06	English
New shares of W to be traded on November 5, 2024 Share Issue/Capital Change	2024-11-04	English
No Right Adjustment of W-W6 Regulatory Filings	2024-11-01	English
Determination of the date for payment and subscription of newly issued ordinary shares to be allocated through Private Placement (For the 11th time) Capital/Financing Update	2024-11-01	English
Progress Report on the Acquisition of Ordinary Shares of Fruita Biomed Company Limited as approved by Shareholders Regulatory Filings	2024-10-31	English
Report on the results of sale of common shares offered to private placement (F53-5) Share Issue/Capital Change	2024-10-31	English
New shares of W to be traded on October 31, 2024 Share Issue/Capital Change	2024-10-30	English
No Right Adjustment of W-W5,W-W6 Regulatory Filings	2024-10-29	English
Determination of the date for payment and subscription of newly issued ordinary shares to be allocated through Private Placement (For the 10th time) Capital/Financing Update	2024-10-29	English
Report on the results of sale of common shares offered to private placement (F53-5) Share Issue/Capital Change	2024-10-28	English
New shares of W to be traded on October 29, 2024 Share Issue/Capital Change	2024-10-28	English
No Right Adjustment of W-W5,W-W6 Regulatory Filings	2024-10-24	English
Determination of the date for payment and subscription of newly issued ordinary shares to be allocated through Private Placement (For the 9th time) Capital/Financing Update	2024-10-24	English
Report on the results of sale of common shares offered to private placement (F53-5) Share Issue/Capital Change	2024-10-24	English
No Right Adjustment of W-W5,W-W6 Regulatory Filings	2024-10-18	English
Determination of the date for payment and subscription of newly issued ordinary shares to be allocated through Private Placement (For the 8th time) Capital/Financing Update	2024-10-18	English
07 October 2024 is the last trading day of W-W5 Regulatory Filings	2024-10-03	English
Progress Report on the Acquisition of Ordinary Shares of Fruita Biomed Company Limited as approved by Shareholders and the Repayment of Short-term Loans to Peer for You Public Company Limited. Regulatory Filings	2024-09-30	English
New shares of W to be traded on September 17, 2024 Share Issue/Capital Change	2024-09-16	English
Report on the results of sale of common shares offered to private placement (F53-5) Share Issue/Capital Change	2024-09-12	English
No Right Adjustment of W-W5,W-W6 Regulatory Filings	2024-09-09	English
Determination of the date for payment and subscription of newly issued ordinary shares to be allocated through Private Placement (For the 7th time) Capital/Financing Update	2024-09-09	English
Trading Suspension and termination of listing status of W-W5 Delisting Announcement	2024-08-28	English
Notification the final exercise and request for suspension of W-W5 Share Issue/Capital Change	2024-08-26	English
Report of the Public Presentation Management Reports	2024-08-22	English
Notification convening date of the Public Presentation Report Publication Announcement	2024-08-15	English
New shares of W to be traded on August 16, 2024 Share Issue/Capital Change	2024-08-15	English
Management Discussion and Analysis Quarter 2 Ending 30 Jun 2024 Management Reports	2024-08-14	English
Financial Performance Quarter 2 (F45) (Reviewed) Earnings Release H1 2024	2024-08-14	English
Financial Statement Quarter 2/2024 (Reviewed) Regulatory Filings	2024-08-14	English
Report on the results of sale of common shares offered to private placement (F53-5) Share Issue/Capital Change	2024-08-13	English
Determination of the date for payment and subscription of newly issued ordinary shares to be allocated through Private Placement (For the 6th time) (Revised) Share Issue/Capital Change	2024-08-02	English
No Right Adjustment of W-W5,W-W6 Regulatory Filings	2024-08-01	English
Determination of the date for payment and subscription of newly issued ordinary shares to be allocated through Private Placement (For the 6th time) Share Issue/Capital Change	2024-08-01	English
New shares of W to be traded on August 1, 2024 Share Issue/Capital Change	2024-07-31	English
Report on the use of proceeds from capital increase received from the offering of the newly issued ordinary shares to Private Placement Regulatory Filings	2024-07-26	English
Report on the results of sale of common shares offered to private placement (F53-5) Share Issue/Capital Change	2024-07-26	English
No Right Adjustment of W-W5,W-W6 Regulatory Filings	2024-07-16	English
Determination of the date for payment and subscription of newly issued ordinary shares to be allocated through Private Placement (For the 5th time) Share Issue/Capital Change	2024-07-16	English
New shares of W to be traded on July 16, 2024 Share Issue/Capital Change	2024-07-15	English
Report on the results of sale of common shares offered to private placement (F53-5) Share Issue/Capital Change	2024-07-08	English
New shares of W to be traded on July 5, 2024 Share Issue/Capital Change	2024-07-04	English
No Right Adjustment of W-W5,W-W6 Regulatory Filings	2024-07-01	English
Determination of the date for payment and subscription of newly issued ordinary shares to be allocated through Private Placement (For the 4th time) Share Issue/Capital Change	2024-07-01	English
Report on the results of sale of common shares offered to private placement (F53-5) Share Issue/Capital Change	2024-06-28	English
New shares of W to be traded on June 28, 2024 Share Issue/Capital Change	2024-06-27	English
No Right Adjustment of W-W5,W-W6 Regulatory Filings	2024-06-25	English
Determination of the date for payment and subscription of newly issued ordinary shares to be allocated through Private Placement (For the 3rd time) Capital/Financing Update	2024-06-25	English
Report on the results of sale of common shares offered to private placement (F53-5) Share Issue/Capital Change	2024-06-21	English
Determination of the date for payment and subscription of newly issued ordinary shares to be allocated through Private Placement (For the second time) (Revised) Capital/Financing Update	2024-06-17	English
No Right Adjustment of W-W5,W-W6 Regulatory Filings	2024-06-14	English
Determination of the date for payment and subscription of newly issued ordinary shares to be allocated through Private Placement (For the second time) Capital/Financing Update	2024-06-14	English
The registration of the change in paid-up capital of Wow Factor Public Company Limited and report on the results of sale of common shares offered to specific persons (Private Placement) Share Issue/Capital Change	2024-05-31	English
New shares of W to be traded on June 4, 2024 Share Issue/Capital Change	2024-05-31	English
Report on the results of sale of common shares offered to private placement (F53-5) Share Issue/Capital Change	2024-05-29	English
No Right Adjustment of W-W5,W-W6 Regulatory Filings	2024-05-29	English
Management Discussion and Analysis Quarter 1 Ending 31 Mar 2024 (Revised) Management Reports	2024-05-28	English
Financial Statement Quarter 1/2024 (Reviewed) (Revised) Regulatory Filings	2024-05-28	English
Determination of the date for payment and subscription of newly issued ordinary shares to be allocated through Private Placement (Revised PDF) Capital/Financing Update	2024-05-23	English
Determination of the date for payment and subscription of newly issued ordinary shares to be allocated through Private Placement (Revised) Share Issue/Capital Change	2024-05-21	English
Report of the Public Presentation Management Reports	2024-05-21	English
Notification convening date of the Public Presentation Report Publication Announcement	2024-05-15	English
Publication of the Minutes of 2024 Annual General Meeting of Shareholders on the Company's Website Report Publication Announcement	2024-05-14	English
Financial Statement Quarter 1/2024 (Reviewed) (Revised) Regulatory Filings	2024-05-14	English
Management Discussion and Analysis Quarter 1 Ending 31 Mar 2024 Management Reports	2024-05-13	English
Financial Performance Quarter 1 (F45) (Reviewed) Regulatory Filings	2024-05-13	English
Financial Statement Quarter 1/2024 (Reviewed) Regulatory Filings	2024-05-13	English
Shareholders meeting's resolution Declaration of Voting Results & Voting Rights Announcements	2024-04-30	English
Opinion of the IFA on the Issuance and Offering of New Ordinary Shares of the Company through Private Placement, which is considered as a Significant Transaction and the Acquisition of Assets and Conn Regulatory Filings	2024-04-17	English
Opinion of the Independent Financial Advisor on the Issuance and Offering of New Ordinary Shares of the Company through Private Placement, which is considered as a Significant Transaction and the Acqu Regulatory Filings	2024-04-09	English
Disclosure of the Invitation Letter of the AGM 2024 and the Annual Registration Statement/Annual Report for the Year 2023 (Form 56-1 One Report) on the Company's Website. Report Publication Announcement	2024-04-09	English
Management Discussion and Analysis Yearly Ending 31 Dec 2023 (Revised : Additional clarification under SET requested) Management Reports	2024-04-02	English
Changing of CFO Board/Management Information	2024-03-29	English
Adding agenda items for the 2024 Annual General Meeting of Shareholders: to consider and approve the acquisition of ordinary shares in Fruita Biomed and the entering into the connected transaction (Re Regulatory Filings	2024-03-08	English
Adding agenda items for the 2024 Annual General Meeting of Shareholders: to consider and approve the acquisition of ordinary shares in Fruita Biomed and the entering into the connected transaction (Re Regulatory Filings	2024-03-05	English
Adding agenda items for the 2024 Annual General Meeting of Shareholders: to consider and approve the acquisition of ordinary shares in Fruita Biomed and the entering into the connected transaction (Re Regulatory Filings	2024-03-04	English
Provide information to the investors and concerned persons (Public Presentation) regarding the implementation plan to resolve the "C" sign caution Management Reports	2024-02-28	English
Notification convening date of the e-Public Presentation Report Publication Announcement	2024-02-22	English
Appointment of Company Secretary, member of the AC and new director, the omission of dividend payment, Amendment to Articles of Association, issuance and allocation of PP and Warrants (W-W7) and deter Regulatory Filings	2024-02-20	English
Appointment of Company Secretary, member of the AC and new director, the omission of dividend payment, Amendment to Articles of Association, issuance and allocation of PP and Warrants (W-W7) and deter Proxy Solicitation & Information Statement	2024-02-19	English
Financial Performance Yearly (F45) (Audited) (Revised) Regulatory Filings	2024-02-16	English
Financial Performance Yearly (F45) (Audited) (Revised) Regulatory Filings	2024-02-16	English
Resolution BOD: Appointment of Company Secretary, member of the audit committee and new director, the omission of dividend payment, Amendment to Articles of Association, Allocation of new shares issua Proxy Solicitation & Information Statement	2024-02-16	English
Management Discussion and Analysis Yearly Ending 31 Dec 2023 Management Reports	2024-02-16	English
Financial Performance Yearly (F45) (Audited) Report Publication Announcement	2024-02-16	English
Financial Statement Yearly 2023 (Audited) Regulatory Filings	2024-02-16	English
Inform result of invitation for the proposal of agenda and nominate candidates for election as directors in advance of the AGM 2024 Regulatory Filings	2024-02-05	English
Information Memorandum Description, Conditions, Key Features of the Warrants to Purchase the Ordinary Shares of WOW Factor Public Company Limited No. 6 (W-W6) Regulatory Filings	2024-02-01	English
SET adds new listed securities : W-W6 to be traded on February 2, 2024 Share Issue/Capital Change	2024-02-01	English
Report on utilization of proceeds received from capital increase by offering the newly issued ordinary shares to Private Placement and Rights Offering (Revised) Regulatory Filings	2024-01-31	English
Report on utilization of proceeds received from capital increase by offering the newly issued ordinary shares to Private Placement and Rights Offering Regulatory Filings	2024-01-29	English
The extension of debt repayment period of short-term loan Capital/Financing Update	2024-01-26	English
Report on the results of the sale of warrants offered to shareholders who subscribe for additional shares (F53-5) (Revised) Share Issue/Capital Change	2024-01-24	English
Report on the results of the sale of warrants offered to All common shares' shareholders (F53-5) Share Issue/Capital Change	2024-01-24	English
New shares of W to be traded on January 8, 2024 Share Issue/Capital Change	2024-01-05	English